Cohance Lifesciences announces ā¹230 mn investment and progress on cGMP Oligonucleotide facility atā¦
Integrated with a pilot plant for early-stage synthesis and for non-GMP scale-up, the facility will add fit-for-purpose GMPā¦
Browsing Category
Infrastructure
Nymi, Caliber Technologies partner to enable Passwordless Authentication in Pharma Manufacturing
This collaboration aims to strengthen MES, LIMS, and QMS automation by reducing manual logins and streamlining electronicā¦
Hyderabad emerges as one of the top global centres of life sciences manufacturing activity
Gross office leasing space by life sciences firms in India increased by ~56 per cent Y-o-Y to 5.8 mn. sq. ft., the highest-ever inā¦
Integrated research campuses: Future of Hyderabadās life sciences industry
Vishal Goel, MD, RX Propellant outlines how transitioning from isolated industrial clusters to integrated research campuses canā¦
Indegene expands presence in Europe, opens new centre in London
The company aims to strengthen its existing employee base in the region
Sovereign Pharma gains EU approval for aseptic and terminally sterilised injectable products
The company has invested an additional 30 million euros to upgrade its existing facilities and is set to be in line for productionā¦
OneSource gains EIR with VAI classification from USFDA for its BLD Facility
The report follows an inspection of the facility, conducted from November 14 to November 22, 2024
Merck inaugurates the expansion of its Peenya facility in Bengaluru
The expansion will transform Peenya into a key manufacturing hub for Merck in the APAC region
Emcure Pharma inaugurates R&D centre in Ahmedabad
The Emcure Research Centre (ERC) aims to enable breakthroughs in complex drug delivery systems, such as sustained-releaseā¦
Venus Remedies secures EU GMP renewal from Infarmed, Portugal
This renewal is applicable to the company's manufacturing facility for Cephalosporin, Carbapenem, and Oncology (Liquid andā¦
ACG launches new capsule manufacturing facility in Thailand
The new facility is dedicated to the production of empty hard gelatin capsules and is strategically located to serve key marketsā¦
US FDA classifies Biocon Biologics site as VAI
The VAI classification was given to Biocon Biologicsā Insulins facilities in Johor Bahru, Malaysia
Lilly to establish new global capability centre in Hyderabad
The Lilly Capability Centre India is expected to open in mid-2025 and will focus on expanding capabilities in automation, AI,ā¦
Sustaining excellence: The evolving role of quality in pharma
In the ever-evolving landscape of the pharma industry, the pursuit of quality remains a cornerstone of success. As stringentā¦
Akums announces new facility for lyophilized and sterile dosage manufacturing
In addition to lyophilized injectables, the facility is equipped to manufacture vials, ampoules, form-fill-seal (FFS) products,ā¦
AstraZeneca invests $3.5 bn in R&D and manufacturing in the US
These US investments are the first of a series of important steps to help deliver AstraZenecaās ambition to achieve $80 billion inā¦
Aptar pharma announces expansion of new facility in Taloja
With the new facility, Aptar aims to meet the regionās growing needs by adding 4400 m2 of manufacturing footprint
Ciplaās manufacturing facility in Goa gets VAI classification
The US FDA conducted a cGMP inspection between June 10-21, 2024
Biocon Biologicsā Bengaluru unit gets VAI classification by US FDA
This relates to the cGMP inspection conducted by the agency between February 20-28, 2024
PM Modi inaugurates Lyfius Pharmaās flagship Penicillin-G facility
Under the Production Linked Incentive (PLI) scheme, Lyfius Pharma invested ā¹2,500 crores in its Penicillin-G (Pen-G) facility atā¦